about
Can broader diffusion of value-based insurance design increase benefits from US health care without increasing costs? Evidence from a computer simulation modelCost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug usersCost-effectiveness analysis of risk-factor guided and birth-cohort screening for chronic hepatitis C infection in the United StatesThe boomers are coming: a total cost of care model of the impact of population aging on health care costs in the United States by Major Practice Category.Uncoupling lifespan and healthspan in Caenorhabditis elegans longevity mutants.Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis.Cost effectiveness of fibrosis assessment prior to treatment for chronic hepatitis C patients.Aging risk and health care expenditure in KoreaAn integrated health-economic analysis of diagnostic and therapeutic strategies in the treatment of moderate-to-severe obstructive sleep apnea.Sofosbuvir-based treatment regimens for chronic, genotype 1 hepatitis C virus infection in U.S. incarcerated populations: a cost-effectiveness analysisLong-Term Cost-Effectiveness of Upper Airway Stimulation for the Treatment of Obstructive Sleep Apnea: A Model-Based Projection Based on the STAR TrialPrevalence of comorbid conditions with aging among patients with diabetes and cardiovascular disease.Assessing the Complex and Evolving Relationship between Charges and Payments in US Hospitals: 1996 - 2012New protease inhibitors for the treatment of chronic hepatitis C: a cost-effectiveness analysisThe cost of an additional disability-free life year for older Americans: 1992-2005Patient time costs associated with cancer care.Counting backward to health care's future: using time-to-death modeling to identify changes in end-of-life morbidity and the impact of aging on health care expendituresThe cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men.Effect of including cancer mortality on the cost-effectiveness of aspirin for primary prevention in menCost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease.Cost-effectiveness of preoperative imaging for appendicitis after indeterminate ultrasonography in the second or third trimester of pregnancy.The impact of technological intensity of service provision on physician expenditures: an exploratory investigation.Adjusting health spending for the presence of comorbidities: an application to United States national inpatient dataIndoles from commensal bacteria extend healthspan.The effect of population aging on health expenditure growth: a critical review.A Cost-effectiveness Analysis of Preexposure Prophylaxis for the Prevention of HIV Among Los Angeles County Men Who Have Sex With Men.Toward development of evidenced-based quality parameters: What gets counted and who gets paid?How a Mutation that Slows Aging Can Also Disproportionately Extend End-of-Life Decrepitude.Genetic testing in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a cost-effectiveness analysis.Heterogeneity in the smoking response to health shocks by out-of-pocket spending risk.Cost consciousness among physicians in the neonatal intensive care unit.Mobile and traditional cognitive behavioral therapy programs for generalized anxiety disorder: A cost-effectiveness analysis.Medical Spending of the US Elderly
P2860
Q21144630-923BC319-2CE5-4387-A941-0052F97E86E7Q28483820-1423FC07-4C1F-4E7B-AC82-F42E64BD7E37Q28488762-E7CE2245-20EE-413C-B604-93D6A40119A3Q30479984-28E2ADB3-7AB2-4A50-87AC-55AEF90FD21CQ30619301-69DF5A14-03E2-4806-92F1-20F9C21B192AQ34073478-D9E378B4-3D72-4116-A3C8-6D84D1DE0A71Q34098870-468F1A4E-1DE0-44B7-B4F3-AF79E90B7407Q34196927-27849984-1BDB-4E41-B182-08E2E09D56FBQ34995601-FFE928FF-C8A2-4D39-860F-BE42BCF612E1Q35037688-D79C7AE5-64B9-4808-B305-A6C4B738F034Q35478368-B4CA416A-4B67-40BA-A666-1BBF75310689Q35549791-ED84C3BD-174B-4C35-9742-A885CEFA081BQ36070788-4002A9A9-7B13-42AB-8AF4-F91ACE1DE0B4Q36652084-957E0908-1E61-46AE-9850-8828BFF5DB7BQ36661498-8C84B684-85C8-4CA6-AF20-13D24C79394BQ36698752-6667A6B0-8B42-439F-987C-9C09692BFA56Q36828265-2630EA8A-4181-42FB-AA86-BC633A92A9E3Q36950527-BB537A88-C697-4B84-A81F-AA302D65331CQ37231429-9536738D-4311-408A-B195-3213831E0104Q37693993-A3AB6A3C-331A-4285-9CA5-24A96847B4BDQ37717129-FF602CFD-BA8A-49F3-A9E1-AFFA6E7DAE9AQ38128806-D1183701-C6E8-4959-9182-8664CCA46062Q38602598-754C39DB-C72A-4FDB-B6AE-6C715AFBD7B4Q38615476-B24B0E19-DD36-4B81-9AED-25D2482D94D1Q38626824-2E47B231-0104-4811-9E03-F628CA5C2B4AQ39456029-5A765BB6-14CE-43CF-ACBC-E49ED45D7221Q40700161-0D524186-4B59-442F-9431-651DC308E6BFQ41121850-515F0C2F-8F7B-44CC-8778-775C8859AB37Q44258281-74E3E96D-4C3A-4261-8823-8F72FC19B820Q44844489-7B9FAAAD-2F05-4DBE-B70B-3A76BEACD8CDQ46600546-462157F0-115A-40A8-BB0F-7CC825612B36Q47210185-1AC1FF10-D08C-4E16-9842-70526F5045D4Q56566840-FD8BADC8-B952-4967-A5C3-6481F5D8D6AE
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Trends in medical spending by age, 1963-2000.
@ast
Trends in medical spending by age, 1963-2000.
@en
Trends in medical spending by age, 1963-2000.
@nl
type
label
Trends in medical spending by age, 1963-2000.
@ast
Trends in medical spending by age, 1963-2000.
@en
Trends in medical spending by age, 1963-2000.
@nl
prefLabel
Trends in medical spending by age, 1963-2000.
@ast
Trends in medical spending by age, 1963-2000.
@en
Trends in medical spending by age, 1963-2000.
@nl
P2093
P356
P1433
P1476
Trends in medical spending by age, 1963-2000.
@en
P2093
Chapin White
David M Cutler
Ellen Meara
P304
P356
10.1377/HLTHAFF.23.4.176
P407
P577
2004-07-01T00:00:00Z